CA2194397A1 - (-)-(3r)-3-methyl-4-{4-[4-(4-pyridyl)piperazin-1-yl]phenoxy} butyric acid as cellular adhesion inhibitor - Google Patents

(-)-(3r)-3-methyl-4-{4-[4-(4-pyridyl)piperazin-1-yl]phenoxy} butyric acid as cellular adhesion inhibitor

Info

Publication number
CA2194397A1
CA2194397A1 CA002194397A CA2194397A CA2194397A1 CA 2194397 A1 CA2194397 A1 CA 2194397A1 CA 002194397 A CA002194397 A CA 002194397A CA 2194397 A CA2194397 A CA 2194397A CA 2194397 A1 CA2194397 A1 CA 2194397A1
Authority
CA
Canada
Prior art keywords
optically active
pharmaceutically
ester
active compound
amide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002194397A
Other languages
English (en)
French (fr)
Inventor
Stuart Dennett Mills
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Syngenta Ltd
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/457,538 external-priority patent/US5652242A/en
Priority claimed from GBGB9518188.9A external-priority patent/GB9518188D0/en
Application filed by Individual filed Critical Individual
Publication of CA2194397A1 publication Critical patent/CA2194397A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
CA002194397A 1995-06-01 1996-05-28 (-)-(3r)-3-methyl-4-{4-[4-(4-pyridyl)piperazin-1-yl]phenoxy} butyric acid as cellular adhesion inhibitor Abandoned CA2194397A1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US08/457538 1995-06-01
US08/457,538 US5652242A (en) 1993-03-29 1995-06-01 Heterocyclic derivatives
GBGB9518188.9A GB9518188D0 (en) 1995-09-07 1995-09-07 Optically active derivative
GB9518188.9 1995-09-07

Publications (1)

Publication Number Publication Date
CA2194397A1 true CA2194397A1 (en) 1996-12-05

Family

ID=26307696

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002194397A Abandoned CA2194397A1 (en) 1995-06-01 1996-05-28 (-)-(3r)-3-methyl-4-{4-[4-(4-pyridyl)piperazin-1-yl]phenoxy} butyric acid as cellular adhesion inhibitor

Country Status (31)

Country Link
EP (1) EP0796247A1 (el)
JP (1) JP2885941B2 (el)
KR (1) KR100245957B1 (el)
AT (1) AT406675B (el)
AU (1) AU710105B2 (el)
BE (1) BE1009520A5 (el)
BR (1) BR9606409A (el)
CA (1) CA2194397A1 (el)
CH (1) CH691808A5 (el)
CZ (1) CZ26997A3 (el)
DE (1) DE19680509T1 (el)
DK (1) DK10697A (el)
ES (1) ES2137886B1 (el)
FI (1) FI970393A (el)
GB (1) GB2304340B (el)
GR (1) GR1002702B (el)
HU (1) HUP9700274A3 (el)
IE (1) IE960405A1 (el)
IL (1) IL118477A0 (el)
IT (1) IT1290839B1 (el)
LU (1) LU90008B1 (el)
MC (1) MC2418A1 (el)
MX (1) MX9700379A (el)
NL (1) NL1003243C2 (el)
NO (1) NO307460B1 (el)
NZ (1) NZ308597A (el)
PL (1) PL318440A1 (el)
SE (1) SE510812C2 (el)
SK (1) SK13097A3 (el)
TR (1) TR199700020T1 (el)
WO (1) WO1996038416A1 (el)

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0100158A3 (en) * 1982-07-28 1985-03-27 The Upjohn Company (3-pyridinyl)heteroalkarylalkanols, alkanoic acids and esters
GB8609630D0 (en) * 1986-04-19 1986-05-21 Pfizer Ltd Anti-arrhythmia agents
GB9406144D0 (en) * 1993-03-29 1994-05-18 Zeneca Ltd Heterocyclic compounds
DK0691959T3 (da) * 1993-03-29 1999-04-26 Zeneca Ltd Heterocykliske derivater som blodpladeaggregations-inhibitorer

Also Published As

Publication number Publication date
TR199700020T1 (tr) 1997-04-22
AU710105B2 (en) 1999-09-16
ES2137886B1 (es) 2000-08-16
NL1003243C2 (nl) 1996-12-04
FI970393A0 (fi) 1997-01-30
ES2137886A1 (es) 1999-12-16
NZ308597A (en) 1998-11-25
HU9700274D0 (en) 1997-04-28
BE1009520A5 (fr) 1997-04-01
CH691808A5 (de) 2001-10-31
MX9700379A (es) 1997-04-30
AT406675B (de) 2000-07-25
EP0796247A1 (en) 1997-09-24
SE9700203L (sv) 1997-01-24
ATA900596A (de) 1999-12-15
KR100245957B1 (ko) 2000-04-01
NO970437D0 (no) 1997-01-31
HUP9700274A3 (en) 2000-02-28
IT1290839B1 (it) 1998-12-14
GB2304340B (en) 1998-07-29
CZ26997A3 (en) 1997-08-13
GB9627127D0 (en) 1997-02-19
BR9606409A (pt) 1997-09-30
SK13097A3 (en) 1997-08-06
AU5827296A (en) 1996-12-18
NO970437L (no) 1997-02-20
HUP9700274A2 (hu) 1999-06-28
IE960405A1 (en) 1996-12-11
IL118477A0 (en) 1996-09-12
JP2885941B2 (ja) 1999-04-26
ITMI961113A1 (it) 1997-12-01
JPH09512836A (ja) 1997-12-22
PL318440A1 (en) 1997-06-09
GB2304340A (en) 1997-03-19
MC2418A1 (fr) 1997-05-23
GR1002702B (el) 1997-05-22
DK10697A (da) 1997-04-01
DE19680509T1 (de) 1997-12-04
SE9700203D0 (sv) 1997-01-24
NO307460B1 (no) 2000-04-10
WO1996038416A1 (en) 1996-12-05
SE510812C2 (sv) 1999-06-28
LU90008B1 (fr) 1997-04-16
FI970393A (fi) 1997-01-30
ITMI961113A0 (it) 1996-05-31
KR970704689A (ko) 1997-09-06

Similar Documents

Publication Publication Date Title
EP0478328B1 (en) Novel fibrinogen receptor antagonists
ES2219894T3 (es) Derivados heterociclicos que inhiben el factor xa.
CA2390231A1 (en) Dipeptidyl peptidase iv inhibitors and methods of making and using dipeptidyl peptidase iv inhibitors
SK63194A3 (en) Peptide derivatives
WO1992016549A1 (de) Para-substituierte phenylalanin-derivate
CA2268621A1 (en) 2-pipirazinone-1-acetic acid derivative, production and use thereof
JPH01503063A (ja) 抗炎症組成物
JPH072820A (ja) 不可逆ヒト免疫不全ウイルス（ｈｉｖ）プロテアーゼ阻害剤、その中間体、組成物およびその製法
CA2022112A1 (en) Certain imidazole compounds as transglutaminase inhibitors
CN101790528A (zh) 氨基酰基前药
FR2758329A1 (fr) Derives d'imidazole-4-butane boronique, leur preparation et leur utilisation en therapeutique
CA2252086A1 (en) 6-substituted amino-4-oxa-1-azabicyclo¬3,2,0|heptan-7-one derivatives as cysteine protease inhibitors
CA2070983A1 (en) Cyclic renin inhibitors
CA2194397A1 (en) (-)-(3r)-3-methyl-4-{4-[4-(4-pyridyl)piperazin-1-yl]phenoxy} butyric acid as cellular adhesion inhibitor
SK281025B6 (sk) (1-fenyl-1-heterocyklyl)alkánové deriváty, spôsoby ich prípravy, medziprodukty na ich prípravu, farmaceutické prostriedky s ich obsahom a ich použitie
JPH10175967A (ja) 新規なｎ−ベンジルピペラジン化合物、その製造法及びそれを含有する医薬組成物
HU205951B (en) Process for producing amino-acid derivatives and pharmaceutical compositions containing them
CA2887420A1 (en) Matrix metalloproteinase inhibitors and methods for the treatment of pain and other diseases
NZ306451A (en) Substituted phenyl amidines, medicaments containing these compounds and process for producing them
CN102924567B (zh) 一类肽化合物、其制备方法及用途
CA2022110A1 (en) Azole compounds and their use as transglutaminase inhibitors
CA2230445C (en) Fibrinogen receptor antagonists and medicinal preparations containing the same as the active ingredient
US5817680A (en) Hemoregulatory compounds
CH677610A5 (el)
FR2734818A1 (fr) Acide (-)-(3r)-3-methyl-4-{4-[4-(4-pyridyl)piperazine-1-yl- phenoxy}-butyrique, procede pour sa preparation et composition pharmaceutique le contenant

Legal Events

Date Code Title Description
FZDE Discontinued